Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation

Cyproheptadine has been reported to effect remissions in up to 50% of patients with Cushing's disease presumably at a hypothalamic level. Endocrine studies including CRF testing were performed in a 37-year-old woman with Cushing's disease. Cyproheptadine therapy resulted in a clinical and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of endocrinological investigation 1989-03, Vol.12 (3), p.197-200
Hauptverfasser:	TUCCI, J. R, NOWAKOWSKI, K. J, JACKSON, I. M. D
Format:	Artikel
Sprache:	eng
Schlagworte:	17-Hydroxycorticosteroids - urine Adrenocorticotropic Hormone - blood Adult Biological and medical sciences Corticotropin-Releasing Hormone Cushing Syndrome - drug therapy Cyproheptadine - therapeutic use Endocrinopathies Female Humans Hydrocortisone - blood Hypothalamus. Hypophysis. Epiphysis (diseases) Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Pituitary Gland - drug effects Remission Induction Steroids - blood Steroids - urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!